"Receptors, Immunologic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cell surface molecules on cells of the immune system that specifically bind surface molecules or messenger molecules and trigger changes in the behavior of cells. Although these receptors were first identified in the immune system, many have important functions elsewhere.
| Descriptor ID |
D011971
|
| MeSH Number(s) |
D12.776.543.750.705
|
| Concept/Terms |
Receptors, Immunologic- Receptors, Immunologic
- Immunologic Receptors
- Immunological Receptors
- Receptors, Immunological
- Immunologic Receptor
- Receptor, Immunologic
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Immunologic".
Below are MeSH descriptors whose meaning is more specific than "Receptors, Immunologic".
- Receptors, Immunologic
- Costimulatory and Inhibitory T-Cell Receptors
- Immunophilins
- Integrins
- Leukocyte Immunoglobulin-like Receptor B1
- Lipopolysaccharide Receptors
- Platelet Membrane Glycoproteins
- Receptors, Antigen
- Receptors, Complement
- Receptors, Cytokine
- Receptors, Fc
- Receptors, Formyl Peptide
- Receptors, Laminin
- Receptors, Lymphocyte Homing
- Receptors, Mitogen
- Receptors, Natural Killer Cell
- Receptors, Pattern Recognition
- Receptors, Scavenger
- Signaling Lymphocytic Activation Molecule Family
- Triggering Receptor Expressed on Myeloid Cells-1
This graph shows the total number of publications written about "Receptors, Immunologic" by people in this website by year, and whether "Receptors, Immunologic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1997 | 1 | 0 | 1 |
| 1999 | 1 | 1 | 2 |
| 2000 | 2 | 1 | 3 |
| 2001 | 2 | 0 | 2 |
| 2002 | 4 | 1 | 5 |
| 2003 | 5 | 1 | 6 |
| 2004 | 1 | 2 | 3 |
| 2005 | 5 | 3 | 8 |
| 2006 | 5 | 1 | 6 |
| 2007 | 9 | 2 | 11 |
| 2008 | 1 | 2 | 3 |
| 2009 | 3 | 1 | 4 |
| 2010 | 5 | 0 | 5 |
| 2011 | 4 | 2 | 6 |
| 2012 | 4 | 5 | 9 |
| 2013 | 2 | 2 | 4 |
| 2014 | 8 | 1 | 9 |
| 2015 | 4 | 0 | 4 |
| 2016 | 3 | 1 | 4 |
| 2017 | 4 | 4 | 8 |
| 2018 | 1 | 1 | 2 |
| 2019 | 3 | 0 | 3 |
| 2020 | 4 | 3 | 7 |
| 2021 | 3 | 3 | 6 |
| 2022 | 4 | 4 | 8 |
| 2023 | 0 | 4 | 4 |
| 2024 | 4 | 2 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Receptors, Immunologic" by people in Profiles.
-
Phase I dose escalation study of IO-108, an anti-LILRB2 antibody, in patients with advanced solid tumors. J Immunother Cancer. 2024 Nov 20; 12(11).
-
Comparing neoantigen cancer vaccines and immune checkpoint therapy unveils an effective vaccine and anti-TREM2 macrophage-targeting dual therapy. Cell Rep. 2024 Nov 26; 43(11):114875.
-
Antitumor Activity of a Novel LAIR1 Antagonist in Combination with Anti-PD1 to Treat Collagen-Rich Solid Tumors. Mol Cancer Ther. 2024 Aug 01; 23(8):1144-1158.
-
Neoantigen-specific cytotoxic Tr1 CD4 T cells suppress cancer immunotherapy. Nature. 2024 Aug; 632(8023):182-191.
-
Glioblastoma Phagocytic Cell Death: Balancing the Opportunities for Therapeutic Manipulation. Cells. 2024 May 11; 13(10).
-
Triggering receptor expressed on myeloid cells 2 (TREM2) regulates phagocytosis in glioblastoma. Neuro Oncol. 2024 05 03; 26(5):826-839.
-
LILRB3 Modulates Acute Myeloid Leukemia Progression and Acts as an Effective Target for CAR T-cell Therapy. Cancer Res. 2023 12 15; 83(24):4047-4062.
-
iPSC-derived microglia carrying the TREM2 R47H/+ mutation are proinflammatory and promote synapse loss. Glia. 2024 02; 72(2):452-469.
-
Fc-competent multispecific PDL-1/TIGIT/LAG-3 antibodies potentiate superior anti-tumor T cell response. Sci Rep. 2023 06 18; 13(1):9865.
-
TMEM106B regulates microglial proliferation and survival in response to demyelination. Sci Adv. 2023 05 05; 9(18):eadd2676.